Detailed deletion mapping of chromosome 17q in ovarian and breast cancers: 2-cM region on 17q21.3 often and commonly deleted in tumors
- PMID: 8100738
Detailed deletion mapping of chromosome 17q in ovarian and breast cancers: 2-cM region on 17q21.3 often and commonly deleted in tumors
Abstract
Using 11 restriction fragment length polymorphism markers, we examined loss of heterozygosity on the long arm of chromosome 17, where one or more genes responsible for hereditary breast and ovarian cancers may be present, in sporadic forms of 94 ovarian and 246 breast cancers. Loss of heterozygosity was observed in 33 of 84 (39.3%) ovarian and in 88 of 214 (41.1%) breast cancers that were informative with at least one marker. Detailed deletion mapping of chromosome 17q in these cancers identified two distinct, commonly deleted regions. One was located between 17q12 and 17q21.3 and the other between 17q25.1 and 17q25.3. In breast cancers, the proximal commonly deleted region was between two loci defined by markers CI17-701 and CI17-730 at 17q21.3, which are 2.4 cM apart. This segment overlaps the region that includes the putative gene for hereditary breast and ovarian carcinomas. The results suggest that at least two tumor suppressor genes associated with sporadic ovarian and breast cancers are present on chromosome 17q and that one of them may be the same gene that is responsible for the hereditary form.
Similar articles
-
A deletion unit on chromosome 17q in epithelial ovarian tumors distal to the familial breast/ovarian cancer locus.Cancer Res. 1993 Mar 15;53(6):1218-21. Cancer Res. 1993. PMID: 8095178
-
Frequent loss of heterozygosity in the region including BRCA1 on chromosome 17q in squamous cell carcinomas of the esophagus.Cancer Res. 1994 Apr 1;54(7):1638-40. Cancer Res. 1994. PMID: 7907942
-
Identification of three regions on chromosome 17q in primary human breast carcinomas which are frequently deleted.Cancer Res. 1993 Dec 1;53(23):5617-9. Cancer Res. 1993. PMID: 8242614
-
The search for the familial breast/ovarian cancer gene.Trends Genet. 1993 Jan;9(1):22-6. doi: 10.1016/0168-9525(93)90068-S. Trends Genet. 1993. PMID: 8434413 Review.
-
[Deletion map of human chromosome 11 in lung cancers].Nihon Rinsho. 1996 Feb;54(2):472-7. Nihon Rinsho. 1996. PMID: 8838099 Review. Japanese.
Cited by
-
The role of SIRT1 in autophagy and drug resistance: unveiling new targets and potential biomarkers in cancer therapy.Front Pharmacol. 2024 Sep 30;15:1469830. doi: 10.3389/fphar.2024.1469830. eCollection 2024. Front Pharmacol. 2024. PMID: 39403142 Free PMC article. Review.
-
Autophagy and Apoptosis Specific Knowledgebases-guided Systems Pharmacology Drug Research.Curr Cancer Drug Targets. 2019;19(9):716-728. doi: 10.2174/1568009619666190206122149. Curr Cancer Drug Targets. 2019. PMID: 30727895 Free PMC article.
-
Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene.J Clin Invest. 2003 Dec;112(12):1809-20. doi: 10.1172/JCI20039. Epub 2003 Nov 24. J Clin Invest. 2003. PMID: 14638851 Free PMC article.
-
The apoptosis associated tyrosine kinase gene is frequently hypermethylated in human cancer and is regulated by epigenetic mechanisms.Genes Cancer. 2014 Sep;5(9-10):365-74. doi: 10.18632/genesandcancer.28. Genes Cancer. 2014. PMID: 25352953 Free PMC article.
-
Targeting autophagy in cancer management - strategies and developments.Cancer Manag Res. 2015 Sep 11;7:291-9. doi: 10.2147/CMAR.S34859. eCollection 2015. Cancer Manag Res. 2015. PMID: 26392787 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical